Literature DB >> 18227761

Lipid levels are associated with a regulatory polymorphism of the monoamine oxidase-A gene promoter (MAOA-uVNTR).

Beverly H Brummett1, Stephen H Boyle, Ilene C Siegler, Stephan Zuchner, Allison Ashley-Koch, Redford B Williams.   

Abstract

BACKGROUND: The monoamine oxidase-A (MAOA) gene plays a vital role in the metabolism of neurotransmitters, e.g, serotonin, norepinephrine, and dopamine. A polymorphism in the promoter region (MAOA-uVNTR) affects transcriptional efficiency. Allelic variation in MAOA-uVNTR has been associated with body mass index (BMI). We extended previous work by examining relations among this polymorphism and serum lipid levels. MATERIAL/
METHODS: The sample consisted of 74 males enrolled in a study of caregivers for relatives with dementia. Regression models, adjusted for age, race, group status (caregiver/control), and cholesterol lowering medication (yes/no), were used to examine associations between high verses low MAOA-uVNTR activity alleles and total cholesterol, HDL, LDL, VLDL, LDL/HDL ratio, triglycerides, and BMI.
RESULTS: Higher total cholesterol (p<0.03), LDL/HDL ratio (p<0.01), triglycerides (p<0.02), and VLDL (p<0.02) were associated with low activity MAOA-uVNTR alleles. HDL and LDL were modestly related to MAOA-uVNTR activity, however, they did not reach the conventional significance level (p<0.07 and p<0.10, respectively). BMI (p<0.74) was unrelated to MAOA-uVNTR transcription.
CONCLUSIONS: The present findings suggest that MAOA-uVNTR may influence lipid levels and individuals with less active alleles are at increased health risk.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18227761      PMCID: PMC2759533     

Source DB:  PubMed          Journal:  Med Sci Monit        ISSN: 1234-1010


  28 in total

1.  Association between monoamine oxidase A activity in human male skin fibroblasts and genotype of the MAOA promoter-associated variable number tandem repeat.

Authors:  R M Denney; H Koch; I W Craig
Journal:  Hum Genet       Date:  1999-12       Impact factor: 4.132

2.  Serotonin-related gene polymorphisms and central nervous system serotonin function.

Authors:  Redford B Williams; Douglas A Marchuk; Kishore M Gadde; John C Barefoot; Katherine Grichnik; Michael J Helms; Cynthia M Kuhn; James G Lewis; Saul M Schanberg; Mark Stafford-Smith; Edward C Suarez; Greg L Clary; Ingrid K Svenson; Ilene C Siegler
Journal:  Neuropsychopharmacology       Date:  2002-08-29       Impact factor: 7.853

3.  A regulatory polymorphism of the monoamine oxidase-A gene may be associated with variability in aggression, impulsivity, and central nervous system serotonergic responsivity.

Authors:  S B Manuck; J D Flory; R E Ferrell; J J Mann; M F Muldoon
Journal:  Psychiatry Res       Date:  2000-07-24       Impact factor: 3.222

4.  Role of genotype in the cycle of violence in maltreated children.

Authors:  Avshalom Caspi; Joseph McClay; Terrie E Moffitt; Jonathan Mill; Judy Martin; Ian W Craig; Alan Taylor; Richie Poulton
Journal:  Science       Date:  2002-08-02       Impact factor: 47.728

5.  Genes implicated in serotonergic and dopaminergic functioning predict BMI categories.

Authors:  Bernard F Fuemmeler; Tanya D Agurs-Collins; F Joseph McClernon; Scott H Kollins; Melanie E Kail; Andrew W Bergen; Allison E Ashley-Koch
Journal:  Obesity (Silver Spring)       Date:  2008-02       Impact factor: 5.002

6.  Association analysis of monoamine oxidase A and attention deficit hyperactivity disorder.

Authors:  Deborah C Lawson; Darko Turic; Kate Langley; Helen M Pay; Catherine F Govan; Nadine Norton; Marian L Hamshere; Michael J Owen; Michael C O'Donovan; Anita Thapar
Journal:  Am J Med Genet B Neuropsychiatr Genet       Date:  2003-01-01       Impact factor: 3.568

7.  Cardiovascular stress responses among Asian Indian and European American women and men.

Authors:  Catherine M Stoney; Joel W Hughes; Kristin K Kuntz; Sheila G West; Lisa M Thornton
Journal:  Ann Behav Med       Date:  2002

8.  High activity-related allele of MAO-A gene associated with depressed suicide in males.

Authors:  Lisheng Du; Gabor Faludi; Miklos Palkovits; Peter Sotonyi; David Bakish; Pavel D Hrdina
Journal:  Neuroreport       Date:  2002-07-02       Impact factor: 1.837

9.  Alteration of amine oxidase activity in the adipose tissue of obese subjects.

Authors:  Virgile Visentin; Danielle Prévot; Véronique Durand De Saint Front; Nathalie Morin-Cussac; Claire Thalamas; Jean Galitzky; Philippe Valet; Antonio Zorzano; Christian Carpéné
Journal:  Obes Res       Date:  2004-03

10.  Family-based association study between the monoamine oxidase A gene and obesity: implications for psychopharmacogenetic studies.

Authors:  Beatriz Camarena; Haydee Santiago; Alejandro Aguilar; Elsa Ruvinskis; Jorge González-Barranco; Humberto Nicolini
Journal:  Neuropsychobiology       Date:  2004       Impact factor: 2.328

View more
  4 in total

1.  Lack of association between MAOA-uVNTR variants and excessive daytime sleepiness.

Authors:  Filiz Ozen; Zeynep Yegin; Figen Yavlal; Zuhal Aydan Saglam; Haydar Koc; Ismet Berber
Journal:  Neurol Sci       Date:  2017-02-08       Impact factor: 3.307

2.  Impact of psychological stress on the associations between apolipoprotein E variants and metabolic traits: findings in an American sample of caregivers and controls.

Authors:  Sofia I Iqbal Kring; Beverly H Brummett; John Barefoot; Melanie E Garrett; Allison E Ashley-Koch; Stephen H Boyle; Ilene C Siegler; Thorkild I A Sørensen; Redford B Williams
Journal:  Psychosom Med       Date:  2010-05-13       Impact factor: 4.312

3.  Monoamine oxidase A genotype, childhood trauma, and subclinical atherosclerosis: a twin study.

Authors:  Jinying Zhao; James D Bremner; Jack Goldberg; Arshed A Quyyumi; Viola Vaccarino
Journal:  Psychosom Med       Date:  2013-05-30       Impact factor: 4.312

4.  MAOA promoter methylation and susceptibility to carotid atherosclerosis: role of familial factors in a monozygotic twin sample.

Authors:  Jinying Zhao; Christopher W Forsberg; Jack Goldberg; Nicholas L Smith; Viola Vaccarino
Journal:  BMC Med Genet       Date:  2012-11-02       Impact factor: 2.103

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.